Literature DB >> 34862104

Green synthesis of manganese-cobalt-tungsten composite oxides for degradation of doxycycline via efficient activation of peroxymonosulfate.

Xuewen Luo1, Yujie You1, Mingjun Zhong1, Lin Zhao1, Yingying Liu1, Rongliang Qiu2, Zhujian Huang3.   

Abstract

The advanced oxidation process of peroxymonosulfate activated by solid catalyst is one of the main technologies to solve the pollution of antibiotics in water environment.In this work, a series of composites (MCW) containing Mn, Co, and W were synthesized using green ball milling, which does not produce the three wastes (waste gas, waste water and industrial residue). It shows a unique and high catalytic activity for peroxymonosulfate-based degradation of doxycycline (DC) under the pH condition between 4 and 9, and it can be reused five times. MCW composites remove DC using singlet oxygen and superoxide free radicals, as well as a large number of oxygen vacancies for electron storage. The formation rate of free radicals is determined by the conversion rates of Mn3+/Mn2+ and Co3+/Co2+. In addition, there are three ways to degrade DC to form 18 kinds of intermediates, and the toxicity of all the intermediates were predicted by ECOSAR program. The highly active catalysts obtained using a green synthetic route for the activation of peroxymonosulfate show a great potential for decontamination of antibiotics wastewater.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ball milling; Peroxymonosulfate; Reusability; Singlet oxygen; Toxicity prediction

Mesh:

Substances:

Year:  2021        PMID: 34862104     DOI: 10.1016/j.jhazmat.2021.127803

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

Review 1.  A review on the degradation of acetaminophen by advanced oxidation process: pathway, by-products, biotoxicity, and density functional theory calculation.

Authors:  Mohammad Qutob; Mahmoud A Hussein; Khalid A Alamry; Mohd Rafatullah
Journal:  RSC Adv       Date:  2022-06-22       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.